Grants & Funding

CARRA-PReS Collaborative Research Award


Click here to submit a CARRA-PReS Collaborative Research Award application.

The purpose of this funding mechanism is to support collaborative research activities between CARRA and PReS early career investigators. Early career investigators are defined as faculty (not fellows) less than 10 years from completion of training.   Funds may be used to convene meetings, generate preliminary data and/or to support collaborative pilot studies. The goal is to provide seed funds that allow CARRA and PReS investigators to successfully plan and apply for funds to support larger-scale collaborative research activities.

Project submissions are encouraged to leverage infrastructure of CARRA and PReS, address priority research topics for both communities, engage patients and extend expertise that would otherwise not be possible working with either group alone.

Applications will be evaluated based on: 1) the extent to which the proposed project leverages the infrastructure of CARRA and PReS, 2) topic’s interest and relevance to both CARRA and PReS; 3) Patient-centeredness; and 4) potential to lead to future collaboration(s) between CARRA and PReS.  It is the hope of both organizations that this opportunity will lead to additional funding and a larger initiative!

Funding Amount: €25,000 EUR or $29,766
Application Deadline: December 1, 2021 (by 11:59 CST)
Executive Sign Off: February 1, 2022

Funding/Project Period: April 1, 2022-March 31, 2023

View informational presentation from CARRA-PReS Townhall Q&A


CARRA-PReS Collaborative Research Award Required Submission Materials:

  • Project Summary/Abstract (300 word max)
  • Lay Summary (150 word max)
  • Specific Aims (limit 1 page) (Download template: WORD)
  • Project Timeline (limit 3 pages) (Download template: WORD)
  • Research Plan (limit 3 pages).  Plan should include any plans/goals for larger initiative and potential future funding mechanisms. (Download template: WORD).
  • References (no page limit) (Download template: WORD)
  • Budget Table (2 page limit) (Download template: WORD)
    • All Principal Investigators (PI) are required to dedicate effort on their projects which must be noted on the budget table. Requesting salary support is optional. A letter of support from a division chief documenting that the % effort is available, and confirming investigator salary (if applicable) must be submitted with each application. If the PI is the division chief, a letter from the Department Chairperson is required.
  • Budget Justification (Download template: WORD)
    • Up to 8% indirect/overhead costs can be requested.
    • Applicants should aim to allocate approximately half of the budget to CARRA member expenses and half of the budget to PReS member expenses, or justify why this is not possible.
  • NIH-formatted Biosketches for all Principal Investigator(s), Co-Principal Investigator(s), and all Co-Investigator(s) (limit 5 pages per biosketch; please combine all biosketches into one PDF with the PI(s) biosketch listed first). PReS investigators may submit a Curriculum Vitae in lieu of a biosketch.
  • Letters of Support
    • Required for budgets that include investigator salary/effort. Letter should be from division chief documenting that % effort is available, and confirming investigator salary. (If PI is the division chief, a letter from the Department Chairperson is required.)
    • Letters of support from collaborators are required.
    • Letters of support from mentors and institution(s) are highly recommended.
    • Letters of Support from RROC for registry-related applications requesting collection of new data or sample collection. See full details below.
  • Research Assurances
    • Submit documentation of an Institutional Review Board (IRB) review, if applicable. Funds will not be released until either 1) IRB approval letter or 2) IRB waiver/documentation that IRB has determined your project is exempt from IRB review is received.
    • Awards will be relinquished if IRB approval or an IRB waiver is not received by 6 months after the project period start date. 
  • Appendix (limit 1 attachment)

Applicants must use the templates provided when submitting their final applications.

APPLICATIONS NOT FOLLOWING THESE GUIDELINES WILL NOT BE CONSIDERED.


Important Information for CARRA-PReS Collaborative Research Award Submissions

Read the CARRA-PreS Collaborative Research Award instructions carefully. Be sure to be compliant with formatting instructions and page limits. Use of the document templates provided above is REQUIRED. Submit your completed CARRA-PreS Collaborative Research Award application via the online application.

  • If you are requesting infrastructure support from CARRA or PReS, you must email [email protected] with a brief summary of your request no later November 1, 2021 to arrange a phone call to discuss your request.
  • Funds will be provided to the awardee’s institutions to be used by the principal investigator’s according to the project budget. CARRA and PReS will arrange to provide funds to their respective members’ institutions.
  • If the PI’s are unable to complete the project, any unexpended balance must be returned.
  • Awardees are expected to submit an abstract(s) and ensure that the work is presented annually at the CARRA and PReS Annual Meeting(s) until the project is complete.
  • Budgets may not include travel required to present abstracts at CARRA and PReS Annual Meetings.
  • Publication and presentation costs are not allowed.
  • Applicants will be notified of funding decisions by mid-February 2022.
  • If the project is not completed within the project period, the award recipient may request a no-cost extension (NCE) for up to 12 months.  Requests for NCEs can be made up to 90 days prior, but no less than 30 days prior, to the project period end date. An interim progress report must be submitted with the NCE Request Form.  NCE requests will be considered by the review committee but are not guaranteed.
  • Awardees must submit a final progress report no later than 45 days after the project period end date.
  • All awardees must acknowledge the support from this funding mechanism in all presentations and publications related to this project by including the following language: “The authors wish to acknowledge CARRA, and the ongoing Arthritis Foundation financial support of CARRA and PReS for this work.”
  • Recipients must abide by CARRA’s and PReS’s relevant organizational policies and guidelines regarding publications.

Eligibility

  • The application must name two co-PIs, one current CARRA member from North America and one current PReS member from outside North America
  • MD applicants must be at a faculty level (not trainees) to be eligible to submit proposals.
  • Applicants must be CARRA or PReS members in good standing.

Review criteria specific to this RFP

  • Extent to which the proposed project leverages the infrastructure of both CARRA and PReS
  • Addresses topic of interest to both CARRA and PReS
  • Patient-centeredness
  • Potential to lead to future collaboration between CARRA and PReS
  • Preference will be given to early career investigators (as determined by each organization)

 

Email [email protected] with any questions.

 

IMPORTANT UPDATE FOR GRANT APPLICANTS USING CARRA REGISTRY DATA/SAMPLES

Grant applicants that intend to utilize the CARRA Registry or CARRA-related data and/or samples (including Legacy Registry and APPLE data/samples) must receive approval from the CARRA Data Sample Share Committee (DSSC) prior to submitting their grant applications. These requests take 4-6 weeks to process.

For more information on requesting data/samples and to access the request form, please visit the CARRA Data and Samples Request area of the wiki.

The deadline for 2021 CARRA-PReS Award DSSC requests is November 1.

 

Grant applications that propose collection of any new data or biosamples via the CARRA Registry must include a letter of support (LOS) from CARRA’s Research and Registry Oversight Committee (RROC). New data is defined as anything that is not currently collected through the Registry's CRFs. New samples include any new patient cohort or sample types that are not currently collected through CARRA's standard Type 1 or Type 2 kits.

To request an RROC Letter of Support, please complete the CARRA Request Form.

The deadline for 2021 CARRA-PReS Award RROC requests is November 1.